Medication info

Cheil Mineral 5

Prescription medicationInjectionsIntravenous injectionApproval withdrawn
Ingredient · strength
Zinc Sulfate Hydrate›4.39mg / 1mLCopper Sulfate›1.57mg / 1mLManganese Sulfate›0.308mg / 1mLChromic Chloride Hydrate›20.5μg / 1mLSelenious Acid›32.7μg / 1mL
Manufacturer / importer
Cheil Pharmaceutical Co., Ltd.
Appearance
A colorless and transparent vial injection containing a colorless, transparent liquid that is odorless, colorless, or light blue.
Packaging
10 mL × 10 vials
Approval status
Approval withdrawn

MFDS item code 201605827 · Notified 2016.09.30

This product's status changed to Approval withdrawn on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Prevention of trace element deficiencies (such as zinc and copper) during parenteral nutrition
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, checking plasma trace element levels to guide dose adjustment. - Permitted dosage range (for intravenous administration): Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4 mg daily Copper: 0.5∼1.5 mg daily Manganese: 0.15∼0.8 mg daily Chromium: 10∼15 μg daily Selenium: 20∼40 μg daily Other - Patients with small intestinal fluid loss who are metabolically stable: an additional 12.2 mg/L (volume of small intestinal fluid lost) or 17.1 mg/kg (stool output) - Patients in an acute catabolic state: 4.5∼6 mg daily Patients with small intestinal fluid loss who are metabolically stable: 20 μg daily Deficiency due to long-term parenteral nutrition: 100 μg daily may be used for 24∼31 days.
Child administration
Age 5 years and under: zinc 100 μg/kg body weight daily, copper 20 μg/kg body weight daily, manganese 2∼10 μg/kg body weight daily, chromium 0.14∼0.20 μg/kg body weight daily, selenium 3 μg/kg body weight daily

Ingredients

Manufacturer
Cheil Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention of trace element deficiencies (such as zinc and copper) during parenteral nutrition

View approved original text

This medication is used to improve nutritional status by supplementing trace elements such as zinc, copper, manganese, selenium, and chromium needed during intravenous nutrition.

How it is given

Adult administration

Use as prescribed by a physician, checking plasma trace element levels to guide dose adjustment. - Permitted dosage range (for intravenous administration): Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4 mg daily Copper: 0.5∼1.5 mg daily Manganese: 0.15∼0.8 mg daily Chromium: 10∼15 μg daily Selenium: 20∼40 μg daily Other - Patients with small intestinal fluid loss who are metabolically stable: an additional 12.2 mg/L (volume of small intestinal fluid lost) or 17.1 mg/kg (stool output) - Patients in an acute catabolic state: 4.5∼6 mg daily Patients with small intestinal fluid loss who are metabolically stable: 20 μg daily Deficiency due to long-term parenteral nutrition: 100 μg daily may be used for 24∼31 days.

Child administration

Age 5 years and under: zinc 100 μg/kg body weight daily, copper 20 μg/kg body weight daily, manganese 2∼10 μg/kg body weight daily, chromium 0.14∼0.20 μg/kg body weight daily, selenium 3 μg/kg body weight daily

Precautions

This medication contains benzyl alcohol and should not be administered to neonates or premature infants as it could cause fatal respiratory problems. When administering intravenously, do not inject directly without dilution, as this may cause phlebitis; always mix and administer by dilution. This medication is a hypotonic solution, so do not administer it alone; always use it mixed with other injection solutions. If any toxic symptoms appear from any component, treatment should be stopped immediately and medical advice should be followed. Aluminum contained in non-oral nutrition solutions can reach toxic levels in patients with impaired kidney function, especially in immature infants with immature kidneys, so caution is required. Although the amounts of zinc, copper, manganese, chromium, and selenium included in this medication are small, it is important to frequently monitor blood concentrations and adjust dosages according to the patient's condition. Patients with renal failure have difficulty excreting zinc, and zinc may accumulate in the body, so caution is necessary. Patients with biliary obstruction have difficulty excreting copper and manganese, posing a risk for accumulation of these trace elements in the body, thus requiring monitoring. Chromium is primarily excreted through the kidneys and should be administered only after confirming whether the diabetic patient is taking any antidiabetic medications. Selenium may be difficult to excrete in patients with kidney or gastrointestinal dysfunction, so dosage should be adjusted, and in transfusion patients, the effects from the transfusion must be considered. The safety of this drug during pregnancy has not been established, thus it should be administered only when the therapeutic benefits override the risks for pregnant women or those who may become pregnant. Excessive administration may lead to toxic symptoms from trace elements like zinc, copper, chromium, and selenium, and if symptoms appear, medical personnel should be notified immediately. This medication should not be used without a doctor's prescription, and when added to non-oral nutrition solutions, aseptic conditions must be maintained. Before administration, check for discoloration or any particulate matter in the solution and do not use it if any abnormalities are found. Store in a dry, cool place, out of reach of children. Do not transfer to other containers as this may alter the quality; always store in the original container.

Side effects

  • Shortness of breath
  • sweating
  • decreased consciousness
  • blurred vision
  • tachycardia
  • hypothermia
  • hyperamylasemia
  • hypotension
  • pulmonary edema
  • diarrhea
Show 32 more
  • vomiting
  • jaundice
  • decreased urine output
  • weakness
  • behavioral changes
  • progressive wasting syndrome
  • photophobia
  • peripheral edema
  • nausea
  • ulcers
  • gastrointestinal disorders
  • renal impairment
  • liver impairment
  • convulsions
  • coma
  • hair loss
  • nail weakness
  • dermatitis
  • dental damage
  • gastrointestinal disturbances
  • irritability
  • depression
  • metallic taste
  • sweating
  • garlic odor during respiration
  • acute peripheral vascular collapse
  • vascular congestion
  • pulmonary hemorrhage
  • pulmonary congestion
  • pulmonary edema
  • discoloration of the gastric mucosa
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to keep out air and moisture. It is recommended to maintain a storage temperature between 15°C and 30°C. Proper storage will help retain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

A colorless and transparent vial injection containing a colorless, transparent liquid that is odorless, colorless, or light blue.

Package unit

10 mL × 10 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.